id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2787576,7da19b37-e3e0-4e4e-bf99-c95403e38885,Q1,ASSOCIATION FOR CLINICAL ONCOLOGY,401105592,ASSOCIATION FOR CLINICAL ONCOLOGY,2022,first_quarter,HCR,S 464/HR 2163 Safe Step Act - implementing safe guards around step therapy (fail first) programs in ERISA regulated plans HR 1550 - PREVENT HPV Cancers Act of 2021 HR 3258 - TACT Act of 2021- improve patient access to anti-cancer oral medications S 610/HR 1667- Dr. Lorna Breen Health Care Provider Protection Act- address behavioral health and well-being among health care professionals HR 4385/S 3080- Cancer Drug Parity Act of 2021- oral parity HR 5801- HELP Copays Act- copay accumulator programs S 3039/HR 2503- Social Determinants Accelerator Act of 2021- SDOH HR 5030/S 2706- DIVERSE Trials Act- access to clinical trials HR 6584- DEPICT Act- access to clinical trials HR 6000- Cures 2.0 ARPA-H FDA User Fee Agreement Reauthorization,"HOUSE OF REPRESENTATIVES,SENATE",,213980,0,0,2022-04-19T16:58:57-04:00